 Jerome McKay
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 2 | 2017 | 770 | 0.760 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 2 | 2017 | 14 | 0.730 |
Why?
| | Phosphorylcholine | 1 | 2017 | 18 | 0.590 |
Why?
| | Immunoglobulin M | 1 | 2017 | 251 | 0.530 |
Why?
| | Antibody Formation | 1 | 2017 | 273 | 0.530 |
Why?
| | Emergency Medical Services | 4 | 2023 | 591 | 0.500 |
Why?
| | Antibodies, Bacterial | 1 | 2015 | 119 | 0.470 |
Why?
| | Pneumococcal Infections | 1 | 2015 | 91 | 0.460 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 132 | 0.450 |
Why?
| | B7-H1 Antigen | 1 | 2015 | 138 | 0.440 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2015 | 193 | 0.430 |
Why?
| | Wounds and Injuries | 3 | 2023 | 731 | 0.370 |
Why?
| | Lymphocytes | 2 | 2023 | 342 | 0.360 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1754 | 0.340 |
Why?
| | Scrapie | 1 | 2008 | 2 | 0.310 |
Why?
| | Warfare | 1 | 2009 | 75 | 0.310 |
Why?
| | Epigenesis, Genetic | 2 | 2023 | 531 | 0.310 |
Why?
| | Prions | 1 | 2008 | 33 | 0.300 |
Why?
| | Interdisciplinary Communication | 1 | 2009 | 185 | 0.300 |
Why?
| | Immunity, Innate | 3 | 2023 | 733 | 0.260 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1001 | 0.250 |
Why?
| | Hospitals | 1 | 2009 | 582 | 0.240 |
Why?
| | Mice, Knockout | 4 | 2021 | 2607 | 0.230 |
Why?
| | Referral and Consultation | 1 | 2009 | 647 | 0.230 |
Why?
| | Neck Injuries | 1 | 2023 | 20 | 0.220 |
Why?
| | Wounds, Penetrating | 1 | 2023 | 72 | 0.210 |
Why?
| | Blood Transfusion | 2 | 2022 | 277 | 0.210 |
Why?
| | Tranexamic Acid | 1 | 2023 | 40 | 0.210 |
Why?
| | Antifibrinolytic Agents | 1 | 2023 | 50 | 0.200 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2021 | 21 | 0.190 |
Why?
| | Emergency Responders | 1 | 2021 | 33 | 0.190 |
Why?
| | Extremities | 1 | 2021 | 113 | 0.190 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 50 | 0.190 |
Why?
| | Hypotension | 1 | 2021 | 116 | 0.180 |
Why?
| | Military Medicine | 1 | 2021 | 93 | 0.170 |
Why?
| | Shock, Hemorrhagic | 1 | 2021 | 193 | 0.170 |
Why?
| | Immunologic Memory | 1 | 2021 | 312 | 0.170 |
Why?
| | Mice, Inbred C57BL | 3 | 2021 | 4767 | 0.160 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2021 | 389 | 0.160 |
Why?
| | Asthma | 2 | 2021 | 2152 | 0.150 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 302 | 0.150 |
Why?
| | Syndecan-1 | 1 | 2017 | 28 | 0.150 |
Why?
| | Interleukin-5 | 1 | 2017 | 31 | 0.150 |
Why?
| | Antibodies, Blocking | 1 | 2017 | 32 | 0.150 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2017 | 15 | 0.150 |
Why?
| | Lymphocyte Activation | 2 | 2021 | 1056 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2021 | 1033 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2023 | 1706 | 0.120 |
Why?
| | Polysaccharides, Bacterial | 1 | 2015 | 66 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1333 | 0.120 |
Why?
| | Registries | 4 | 2023 | 1773 | 0.120 |
Why?
| | Mice | 4 | 2021 | 15073 | 0.120 |
Why?
| | Cell Proliferation | 2 | 2021 | 2196 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2015 | 111 | 0.120 |
Why?
| | Homeostasis | 1 | 2017 | 576 | 0.110 |
Why?
| | Military Personnel | 1 | 2021 | 526 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 133 | 0.110 |
Why?
| | Immunization | 1 | 2015 | 402 | 0.100 |
Why?
| | Animals | 5 | 2021 | 32121 | 0.100 |
Why?
| | Survival Analysis | 1 | 2015 | 1221 | 0.100 |
Why?
| | Tourniquets | 2 | 2021 | 28 | 0.100 |
Why?
| | Afghan Campaign 2001- | 2 | 2023 | 162 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2023 | 2362 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2015 | 782 | 0.090 |
Why?
| | Cells, Cultured | 1 | 2017 | 3916 | 0.090 |
Why?
| | Transcription Factors | 1 | 2017 | 1530 | 0.080 |
Why?
| | Injury Severity Score | 2 | 2022 | 460 | 0.080 |
Why?
| | Signal Transduction | 2 | 2021 | 4525 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2023 | 12616 | 0.070 |
Why?
| | Sheep | 1 | 2008 | 766 | 0.060 |
Why?
| | Humans | 10 | 2023 | 115900 | 0.060 |
Why?
| | Sorbitol | 1 | 2023 | 15 | 0.060 |
Why?
| | Afghanistan | 1 | 2023 | 108 | 0.050 |
Why?
| | Genotype | 1 | 2008 | 1843 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 76 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 163 | 0.050 |
Why?
| | Abbreviated Injury Scale | 1 | 2021 | 21 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2021 | 13 | 0.050 |
Why?
| | Alternaria | 1 | 2021 | 7 | 0.050 |
Why?
| | Bandages | 1 | 2021 | 32 | 0.050 |
Why?
| | DNA | 1 | 2008 | 1358 | 0.050 |
Why?
| | Adoptive Transfer | 1 | 2021 | 200 | 0.050 |
Why?
| | Telemedicine | 1 | 2009 | 667 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 145 | 0.050 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 157 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2022 | 0.040 |
Why?
| | Plasma | 1 | 2022 | 213 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2209 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 275 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 961 | 0.040 |
Why?
| | Down-Regulation | 1 | 2021 | 605 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1444 | 0.040 |
Why?
| | Allergens | 1 | 2021 | 427 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1216 | 0.040 |
Why?
| | Hemorrhage | 1 | 2021 | 616 | 0.040 |
Why?
| | Phosphorylation | 1 | 2021 | 1560 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2021 | 965 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2021 | 3583 | 0.020 |
Why?
| | Prospective Studies | 1 | 2023 | 6267 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5089 | 0.020 |
Why?
| | Female | 3 | 2021 | 60081 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8002 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9176 | 0.020 |
Why?
| | Male | 2 | 2021 | 56126 | 0.020 |
Why?
| | United States | 1 | 2021 | 12340 | 0.020 |
Why?
| | Adolescent | 1 | 2021 | 17956 | 0.010 |
Why?
| | Child | 1 | 2021 | 18556 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 27083 | 0.010 |
Why?
| | Adult | 1 | 2021 | 30817 | 0.010 |
Why?
|
|
McKay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|